Try our Advanced Search for more refined results

APP Takes Angiomax Patent Extension Fight To Fed. Circ.

By Christopher Norton (November 15, 2011, 6:10 PM EST) -- APP Pharmaceuticals LLC tried to convince the Federal Circuit on Tuesday that it has standing and can prove injury sufficient to challenge the extension of The Medicines Co.'s patent for its anti-coagulant Angiomax in extension proceedings instead of an infringement suit....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!